Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
Key claim: A prospective observational study is assessing sarcopenia and sarcopenic obesity prevalence in people with metabolic and endocrine diseases and whether myokines act as biomarkers or drivers of these conditions.
Abstract
Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.
.
Why this matters
A prospective observational study is assessing sarcopenia and sarcopenic obesity prevalence in people with metabolic and endocrine diseases and whether myokines act as biomarkers or drivers of these conditions.